Insulet (MIL:1PODD) E10: €1.23 (As of Mar. 2026)


MIL:1PODD Insulet Corp MIL:1PODD
62 GF Score
Price €140.20
GF Value €345.27
Valuation Significantly Undervalued
View Full Analysis

What is Insulet E10?

Insulet MIL:1PODD 62 E10 is €1.23 as of Mar. 2026. GuruFocus rates MIL:1PODD with a GF Score™ of 62/100 and a GF Value™ of €345.27 (Significantly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Insulet's adjusted earnings per share data for the three months ended in Mar. 2026 was €1.124. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.23 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Insulet's average E10 Growth Rate was 86.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Insulet was 57.30% per year. The lowest was 18.50% per year. And the median was 42.90% per year.

As of today (2026-07-06), Insulet's current stock price is €140.20. Insulet's E10 for the quarter that ended in Mar. 2026 was €1.23. Insulet's Shiller PE Ratio of today is 113.98.

During the past 13 years, the highest Shiller PE Ratio of Insulet was 5102.50. The lowest was 102.07. And the median was 398.17.


Insulet  (MIL:1PODD) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Insulet's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=140.20/1.23
=113.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Insulet was 5102.50. The lowest was 102.07. And the median was 398.17.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Insulet E10 Related Terms


Insulet E10 Historical Data

* Premium members only.

The historical data trend for Insulet's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Insulet E10 Chart

Insulet Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.14

Insulet Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.76 0.94 1.14 1.23

MIL:1PODD vs GMED, PEN, BRKR: E10 Comparison

For the Medical Devices subindustry, Insulet's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Insulet Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Insulet's Shiller PE Ratio falls into.


MIL:1PODD
62GF Score
Insulet Corp MIL:1PODD
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Insulet E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Insulet's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.124/330.2130*330.2130
=1.124

Current CPI (Mar. 2026) = 330.2130.

Insulet Quarterly Data

per share eps CPI Adj_EPS
201606 -0.071 241.018 -0.097
201609 -0.045 241.428 -0.062
201612 -0.152 241.432 -0.208
201703 -0.159 243.801 -0.215
201706 -0.116 244.955 -0.156
201709 -0.034 246.819 -0.045
201712 -0.101 246.524 -0.135
201803 -0.091 249.554 -0.120
201806 -0.026 251.989 -0.034
201809 0.026 252.439 0.034
201812 0.141 251.233 0.185
201903 0.062 254.202 0.081
201906 0.018 256.143 0.023
201909 0.009 256.759 0.012
201912 0.072 256.974 0.093
202003 -0.027 258.115 -0.035
202006 0.195 257.797 0.250
202009 0.144 260.280 0.183
202012 -0.214 260.474 -0.271
202103 0.000 264.877 0.000
202106 -0.307 271.696 -0.373
202109 0.153 274.310 0.184
202112 0.372 278.802 0.441
202203 0.363 287.504 0.417
202206 -0.473 296.311 -0.527
202209 -0.081 296.808 -0.090
202212 0.227 296.797 0.253
202303 0.318 301.836 0.348
202306 0.360 305.109 0.390
202309 0.693 307.789 0.743
202312 1.320 306.746 1.421
202403 0.672 312.332 0.710
202406 2.406 314.175 2.529
202409 0.973 315.301 1.019
202412 1.327 315.605 1.388
202503 0.462 319.799 0.477
202506 0.277 322.561 0.284
202509 1.056 324.800 1.074
202512 1.230 324.054 1.253
202603 1.124 330.213 1.124

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €1.23 mean?
Insulet (MIL:1PODD) has a E10 of €1.23 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Insulet and its competitors.
Is Insulet's E10 too high?
Insulet's current E10 is €1.23. Overall, Insulet has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Insulet's E10 compare to GMED and PEN?
Insulet's E10 of €1.23 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Insulet and its competitors. Insulet's current E10 is €1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insulet stock overvalued right now?
Based on GuruFocus' analysis, Insulet (MIL:1PODD) is currently considered Significantly Undervalued. The stock's GF Value™ is €345.27, compared to a current price of €140.20 — trading 59.4% below its estimated fair value. The current E10 is €1.23. Insulet's overall GF Score™ is 62/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Insulet (MIL:1PODD), the current E10 is €1.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Insulet (MIL:1PODD) Overvalued in 2026?

Based on GuruFocus' analysis, Insulet stock appears to be undervalued. The current stock price of €140.20 is trading 59.4% below its estimated GF Value™ of €345.27. GuruFocus considers Insulet to be Significantly Undervalued.

Key valuation signals for MIL:1PODD:

  • E10: €1.23
  • GF Value™: €345.27 vs. price of €140.20 (59.4% below fair value)
  • GF Score™: 62/100

No single metric tells the full story. See the MIL:1PODD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Insulet Business Description

Address 100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
62GF Score

Get the complete analysis for MIL:1PODD

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€140.20
Price
€345.27
GF Value